Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer.

Albert M, Schnabel F, Chun J, Schwartz S, Lee J, Klautau Leite AP, Moy L.

Clin Imaging. 2015 Nov-Dec;39(6):987-92. doi: 10.1016/j.clinimag.2015.08.001. Epub 2015 Aug 6.


Can the breast screening appointment be used to provide risk assessment and prevention advice?

Evans DG, Howell A.

Breast Cancer Res. 2015 Jul 9;17:84. doi: 10.1186/s13058-015-0595-y.


Breast Cancer Risk - Genes, Environment and Clinics.

Fasching PA, Ekici AB, Adamietz BR, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2011 Dec;71(12):1056-1066.


Current strategies for the prevention of breast cancer.

Advani P, Moreno-Aspitia A.

Breast Cancer (Dove Med Press). 2014 May 2;6:59-71. doi: 10.2147/BCTT.S39114. eCollection 2014. Review.


Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1228-1235.


Development of a personalized decision aid for breast cancer risk reduction and management.

Ozanne EM, Howe R, Omer Z, Esserman LJ.

BMC Med Inform Decis Mak. 2014 Jan 14;14:4. doi: 10.1186/1472-6947-14-4.


Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Pfeiffer RM, Park Y, Kreimer AR, Lacey JV Jr, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P.

PLoS Med. 2013;10(7):e1001492. doi: 10.1371/journal.pmed.1001492. Epub 2013 Jul 30.


Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.

Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB.

Breast Cancer Res. 2012 Nov 5;14(6):R144. doi: 10.1186/bcr3352.


DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.

Sie AS, Spruijt L, van Zelst-Stams WA, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N.

BMC Womens Health. 2012 May 8;12:12. doi: 10.1186/1472-6874-12-12.


Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers.

Heald B, Edelman E, Eng C.

Eur J Hum Genet. 2012 May;20(5):547-51. doi: 10.1038/ejhg.2011.224. Epub 2012 Jan 4.


Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.

Ståhlbom AK, Johansson H, Liljegren A, von Wachenfeldt A, Arver B.

Fam Cancer. 2012 Mar;11(1):33-40. doi: 10.1007/s10689-011-9495-1.


Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

Pruthi S, Gostout BS, Lindor NM.

Mayo Clin Proc. 2010 Dec;85(12):1111-20. doi: 10.4065/mcp.2010.0414. Review.


Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening.

Graubard BI, Freedman AN, Gail MH.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2430-6. doi: 10.1158/1055-9965.EPI-10-0324. Epub 2010 Sep 14.


Cancer risk assessment for the primary care physician.

Korde LA, Gadalla SM.

Prim Care. 2009 Sep;36(3):471-88. doi: 10.1016/j.pop.2009.04.006.


Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K.

J Natl Cancer Inst. 2009 Mar 18;101(6):384-98. doi: 10.1093/jnci/djp018. Epub 2009 Mar 10. Review.


Genetic assessment of breast cancer risk in primary care practice.

Burke W, Culver J, Pinsky L, Hall S, Reynolds SE, Yasui Y, Press N.

Am J Med Genet A. 2009 Mar;149A(3):349-56. doi: 10.1002/ajmg.a.32643.


Colorectal cancer risk prediction tool for white men and women without known susceptibility.

Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D, Gail MH, Pfeiffer RM.

J Clin Oncol. 2009 Feb 10;27(5):686-93. doi: 10.1200/JCO.2008.17.4797. Epub 2008 Dec 29.


A family history of breast cancer will not predict female early onset breast cancer in a population-based setting.

de Bock GH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Blom J, van Asperen CJ, Cornelisse CJ, Klijn JG, Devilee P, Tollenaar RA, Brekelmans CT, van Houwelingen JC.

BMC Cancer. 2008 Jul 23;8:203. doi: 10.1186/1471-2407-8-203.


Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.

Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K.

Ann Intern Med. 2008 Mar 4;148(5):337-47.


Breast cancer risk-assessment models.

Evans DG, Howell A.

Breast Cancer Res. 2007;9(5):213. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk